Search

Author/Creator Ortmann, Robert

1. Efficacy and safety of tabalumab, an anti-B-cell-activating factor monoclonal antibody, in patients with rheumatoid arthritis who had an inadequate response to methotrexate therapy: results from a phase III multicentre, randomised, double-blind study. Issue 8 (14th April 2015)

Authors:
Smolen, Josef S; Weinblatt, Michael E; van der Heijde, Désirée; Rigby, William F C; van Vollenhoven, Ronald; Bingham, Clifton O; Veenhuizen, Melissa; Gill, Anne; Zhao, Fangyi; Komocsar, Wendy J; Berclaz, Pierre-Yves; Ortmann, Robert; Lee, Chin
Journal:
Annals of the rheumatic diseases
Issue:
Volume 74:Issue 8(2015)
Page Start:
1567
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Efficacy and safety of tabalumab, an anti-BAFF monoclonal antibody, in patients with moderate-to-severe rheumatoid arthritis and inadequate response to TNF inhibitors: results of a randomised, double-blind, placebo-controlled, phase 3 study. Issue 1 (12th August 2015)

Authors:
Schiff, Michael; Combe, Bernard; Dörner, Thomas; Kremer, Joel M; Huizinga, Thomas W; Veenhuizen, Melissa; Gill, Anne; Komocsar, Wendy; Berclaz, Pierre-Yves; Ortmann, Robert; Lee, Chin
Journal:
RMD open
Issue:
Volume 1:Issue 1(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗